http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-32783-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06a29f3b547ac01ad997f53400f286ab |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-33 |
| filingDate | 2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7d7bc3326cdd6f1b4c41eb800d9a72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d792610d3740d26979ba60bb7d0fae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d89a308ac88c943a3423edad8b3766a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6b454c04b46b0f032b7da8aa38bbfb1 |
| publicationDate | 2008-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-32783-U |
| titleOfInvention | METHOD FOR TREATMENT OF SUBRETINAL NEOVASCULAR MEMBRANE AT AGE-RELATED MACULAR DEGENERATION |
| abstract | A method of treating a subretinal neovascular membrane with age-related macular degeneration is carried out by exposing the affected retina to laser radiation with the appropriate energy, which depends on a certain diameter of the subretinal neovascular membrane, and injecting triamcinolone acetonide at a dose of 20 mg in combination with dexamethasone at a dose of 2 mg in the posterior subtenon space in the area of the superior fornix of the conjunctiva of the eye. |
| priorityDate | 2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.